Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H28F2O7 |
Molecular Weight | 490.4931 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(O)=O)[C@@]1(C)C[C@H](O)[C@@]4(F)[C@@]2([H])C[C@H](F)C5=CC(=O)C=C[C@]45C
InChI
InChIKey=QOANMINPJDURAZ-VEGHOPOESA-N
InChI=1S/C26H28F2O7/c1-13-9-15-16-11-18(27)17-10-14(29)6-7-23(17,2)25(16,28)20(30)12-24(15,3)26(13,22(32)33)35-21(31)19-5-4-8-34-19/h4-8,10,13,15-16,18,20,30H,9,11-12H2,1-3H3,(H,32,33)/t13-,15+,16+,18+,20+,23+,24+,25+,26+/m1/s1
Molecular Formula | C26H28F2O7 |
Molecular Weight | 490.4931 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:58:12 GMT 2023
by
admin
on
Sat Dec 16 09:58:12 GMT 2023
|
Record UNII |
1W3NSQ8V5D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
397864-63-0
Created by
admin on Sat Dec 16 09:58:12 GMT 2023 , Edited by admin on Sat Dec 16 09:58:12 GMT 2023
|
PRIMARY | |||
|
10163423
Created by
admin on Sat Dec 16 09:58:12 GMT 2023 , Edited by admin on Sat Dec 16 09:58:12 GMT 2023
|
PRIMARY | |||
|
1W3NSQ8V5D
Created by
admin on Sat Dec 16 09:58:12 GMT 2023 , Edited by admin on Sat Dec 16 09:58:12 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE INACTIVE |
MAJOR
PLASMA
|
||
|
PARENT -> METABOLITE |
FECAL
|
||
|
PARENT -> METABOLITE INACTIVE |
Scientific Literature
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Biological Half-life | PHARMACOKINETIC |
|
IN HEALTHY MALE SUBJECTS |
|
||